EAPC Premium Access

Cost-effectiveness of a cardiovascular polypill strategy (aspirin, atorvastatin, ramipril) for the secondary prevention of cardiovascular disease based on real life improvement in risk factor control

Congress Presentation

About the speaker

Mr Gabriel Rubio

Ferrer Internacional, Barcelona (Spain)
0 follower

4 more presentations in this session

Cardiac rehabilitation is associated with lower 1-year all-cause mortality in primary pulmonary hypertension

Speaker: Mr G. Kleinnibbelink (Nijmegen, NL)


Associations of severity of liver damages with physical function and prognosis in patients with heart failure

Speaker: Mr T. Noda (Sagamihara, JP)


Association of type 2 diabetes mellitus and mortality after coronary artery bypass graft surgery- a meta analysis

Speaker: Ms A. Abdul Razzack (Vijayawada, IN)


How consistent are cost-effectiveness estimates of a cardiovascular polypill strategy for the secondary prevention of cardiovascular disease across different cardiovascular risk equations?

Speaker: Mr D. Carcedo (Barcelona, ES)


Access the full session

Rapid fire abstracts - Secondary Prevention and Rehabilitation

Speakers: Mr G. Rubio, Mr G. Kleinnibbelink, Mr T. Noda, Ms A. Abdul Razzack, Mr D. Carcedo

About the event


ESC Preventive Cardiology 2021

15 April - 17 April 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk